VMT Scientific Inc. is a medical technology company that focuses on the development, design, and commercialization of advanced vascular access solutions and specialized biomedical devices. The company develops clinical tools and therapeutic systems primarily for patients with vascular disorders and end-stage renal disease undergoing hemodialysis treatment. Its core product and service portfolio includes vascular access maintenance devices; proprietary arteriovenous fistula and graft protection systems; specialized catheter technologies engineered to reduce infection, stenosis, and thrombosis risks; minimally invasive endovascular delivery tools; and biomedical engineering research and development services aimed at enhancing vascular patency and patient outcomes. VMT Scientific Inc. serves healthcare systems, outpatient hemodialysis centers, nephrology clinics, and vascular surgery centers primarily across North America. In recent developments, the company executed a corporate reorganization and strategic shift toward proprietary medical device development, including rebranding to VMT Scientific Inc. to align with its biomedical technology mandate. Additionally, the company has broadened its intellectual property portfolio with patent filings for advanced vascular access technologies, progressed preclinical validation studies for its next-generation device pipeline, and engaged in strategic discussions for clinical development collaborations and commercial distribution partnerships. Founded in 2007 and headquartered in the United States, VMT Scientific Inc. conducts its business operations across North America.